“The positive outlook reflects the significant strengthening of the center’s balance sheet in fiscal 2015, driven by its investment in Juno Therapeutics and subsequent liquidation of a portion of that stock, which significantly bolstered its cash and investment levels,” said S&P analyst Jessica Matsumori.
“The center now has good financial resource ratios for the rating, which we believe may grow to levels more consistent with a higher rating during the next two years,” she added.
More articles on healthcare finance:
Officials nix closure, extend Laurel Regional’s inpatient services
RCM company Health Check expands with new Missouri office
How is Montana’s Medicaid expansion working so far?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
